AU Patent

AU2015200243B2 — Controlled release formulations

Assigned to Egalet Ltd · Expires 2016-09-29 · 10y expired

What this patent protects

Abstract The present invention relates to the field of controlled release formulations, and in particular to formulations useful for once daily administration. More particular, the present invention relates to compositions, which are formulated for continued administration to an …

USPTO Abstract

Abstract The present invention relates to the field of controlled release formulations, and in particular to formulations useful for once daily administration. More particular, the present invention relates to compositions, which are formulated for continued administration to an individual in need thereof within the range of 20 to 28 hours interval between individual administrations

Drugs covered by this patent

Patent Metadata

Patent number
AU2015200243B2
Jurisdiction
AU
Classification
—
Expires
2016-09-29
Drug substance claim
No
Drug product claim
No
Assignee
Egalet Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.